Quick Answer
Disc Medicine, Inc. reported Diluted EPS of $6.01 per share (loss) for fiscal year 2025.
Disc Medicine, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$6.01 | -51.8% |
| 2024 | -$3.96 | -15.8% |
| 2023 | -$3.42 | +92.4% |
| 2022 | -$45.05 | -10.0% |
| 2021 | -$40.95 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.77 | -98.9% | -12.0% |
| June 30, 2025 | -$1.58 | -53.4% | -54.9% |
| March 31, 2025 | -$1.02 | +6.4% | -14.6% |
| September 30, 2024 | -$0.89 | -53.4% | +13.6% |
| June 30, 2024 | -$1.03 | -39.2% | +5.5% |
| March 31, 2024 | -$1.09 | +9.2% | -87.9% |
| September 30, 2023 | -$0.58 | +96.6% | +21.6% |
| June 30, 2023 | -$0.74 | +92.7% | +38.3% |
- Disc Medicine, Inc. showed a decrease of -51.8% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, Disc Medicine, Inc.’s diluted eps has grown by 85.3% (from $40.95 per share (loss) to $6.01 per share (loss)).
- The most recent figure is from Disc Medicine, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: